|
Resolution: standard / high Figure 3.
1H NMR spectra. Sorafenib in DMSO (a); SORA-NP, sorafenib-incorporated nanoparticles in DMSO (b); and SORA-NP in D2O (c). The box shows typical peaks of sorafenib (a), and the arrow shows typical peaks
of PLGA (b).
Kim et al. Nanoscale Research Letters 2012 7:91 doi:10.1186/1556-276X-7-91 |
